Objectives This 2023 update of the WFSBP guidelines for the pharmacological treatment of
eating disorders (EDs) reflects the latest diagnostic and psychopharmacological progress …

The pharmacological treatment of patients with an eating disorder (ED) often includes
medications to treat their ED, comorbid mental health problems, malnutrition and the …

To examine the hypothesis that normalization of low circulating leptin levels in patients with
anorexia nervosa ameliorates hyperactivity, three seriously ill females with hyperactivity …

Anorexia nervosa (AN) is a devastating psychiatric disorder characterized by extreme
restriction of food intake and low body weight, both associated with significant medical and …

Anorexia nervosa (AN) is a serious psychiatric illness with a high mortality rate and a poor
outcome. AN in adolescents can be difficult to treat. The prognosis of patients with AN …

Eating disorders (EDs) are serious, life-threatening psychiatric conditions associated with
physical and psychosocial impairment, as well as high morbidity and mortality. Given the …

Anorexia nervosa (AN) is a disabling, costly and potentially deadly illness. Treatment failure
and relapse are common after completing treatment, and a substantial proportion of patients …

People with eating disorders suffer from a mental disorder that negatively affects their
physical and/or mental health. The three most frequent eating disorders are binge eating …

The interweaving of malnutrition and symptoms of anxiety and depression in anorexia
Nervosa (AN) is mentioned without any consensus regarding the course of anxious …

Eating disorders are potentially life-threatening conditions characterized by disordered
eating and weight-control behaviors that impair physical health and psychosocial …